Trial intelligence / Profile preview

SB-705498 in chronic cough

2010-021642-22Phase 2Completed

Sponsor
GSK
Start
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of SB-705498 in chronic cough (3 arms), sponsored by GSK. Primary endpoints: Exposure to SB-705498, Capsaicin-induced cough and 1 more. Started Dec 2010; status: completed.

02

Drugs

SB-705498
03

Conditions

chronic cough

Beyond the preview

Go deeper on 2010-021642-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-021642-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call